Loading…

P661 Comparable clinical efficacy, safety and immunogenicity of infliximab biosimilar (CT-P13) after transition from reference infliximab (Remicade®) in children with established inflammatory bowel disease: a multi-centre prospective observational study

Saved in:

Bibliographic Details
Published in:	Journal of Crohn's and colitis 2017-02, Vol.11 (suppl_1), p.S418-S418
Main Authors:	Sladek, M., Vultaggio, A., Ghione, S., Nencini, F., Matucci, A., Pratesi, S., Zanieri, F., Maggi, P.M., Paci, M., Ponanta-Gawron, K., Kulig, K., Wasilewska, A., Lionetti, P.
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!